Peripheral Neuropathic Pain Clinical Trial
Official title:
Safety and Performance of the BlueWind Medical Reprieve System for the Treatment of Patients With Peripheral Neuropathic Pain
The BlueWind Reprieve system is a neurostimulator consisting of an Implant and external
components.
The system is intended for home care use. The chronic pain treatment is achieved by an
electrical stimulation of peripheral nerve fibers. The stimulation is set so that it
generates paresthesia in the stimulated area (e.g. foot), reducing the pain sensation and
improving the quality of life for the patient.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03733886 -
Burst Spinal Cord Stimulation for Neuropathic Pain.
|
N/A | |
| Completed |
NCT04494815 -
A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04431778 -
Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain
|
Phase 2 | |
| Completed |
NCT03191136 -
Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT02100046 -
Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain.
|
Phase 2 | |
| Completed |
NCT05416931 -
ACD440 Gel in Peripheral Neuropathic Pain
|
Phase 2 | |
| Completed |
NCT06234917 -
Increasing Sensori-Motor Rhythm Activity by EEG-Neurofeedback to Reduce the Impact of Pain on Daily Functioning
|
N/A | |
| Completed |
NCT03009500 -
Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain
|
Phase 3 | |
| Completed |
NCT01524796 -
NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark
|
||
| Completed |
NCT02985216 -
Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain
|
Phase 3 | |
| Recruiting |
NCT04171453 -
Post-marketing Surveillance (PMS) to Observe the Safety and Effectiveness of Lyrica CR Extended Release Tablets
|
||
| Completed |
NCT01737294 -
Observation of the Use of QUTENZA™ in Standard Clinical Practice
|
N/A | |
| Active, not recruiting |
NCT05890053 -
To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral Neuralgia
|
Phase 3 | |
| Completed |
NCT05219812 -
A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain
|
Phase 2 | |
| Terminated |
NCT01293851 -
Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage
|
||
| Completed |
NCT01240148 -
Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT05817591 -
Response Profiles to High-concentration Capsaicin Desensitization in Patients With Peripheral Neuropathic Pain With or Without Allodynia: a Regional Multicenter Prospective Cohort
|